Matches in Wikidata for { <http://www.wikidata.org/entity/Q64150354> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q64150354 description "clinical trial" @default.
- Q64150354 description "ensayu clínicu" @default.
- Q64150354 description "klinisch onderzoek" @default.
- Q64150354 description "клінічне випробування" @default.
- Q64150354 name "Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)" @default.
- Q64150354 type Item @default.
- Q64150354 label "Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)" @default.
- Q64150354 prefLabel "Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)" @default.
- Q64150354 P1050 Q64150354-766FC8DB-FDD7-4BC1-9441-8A974D4C37E6 @default.
- Q64150354 P1132 Q64150354-9C976B6B-35E4-4BD3-8F69-DAF06A26C9F5 @default.
- Q64150354 P1476 Q64150354-75F08555-EE45-42F6-9648-10A7988FCB10 @default.
- Q64150354 P17 Q64150354-CA9C5E80-2253-4D69-8CD0-1E1427085452 @default.
- Q64150354 P1813 Q64150354-7F57D62A-7BE5-41CD-9A7C-A83A83E7D311 @default.
- Q64150354 P2899 Q64150354-4CD75E0A-05BB-4734-8654-4A036F91DD0A @default.
- Q64150354 P3098 Q64150354-59965CAF-BB25-47F3-9EBC-E2E23A3C5F27 @default.
- Q64150354 P31 Q64150354-EF50959A-9006-4E5A-8A09-BAF1AD0F71CD @default.
- Q64150354 P4844 Q64150354-765BED3A-02FC-46BA-A1EA-405844FBF05F @default.
- Q64150354 P4844 Q64150354-A1ED160A-38AE-4D40-9C0E-D28992577113 @default.
- Q64150354 P580 Q64150354-B1F29EBC-D02E-40CD-9A69-ED2A260E8EA7 @default.
- Q64150354 P582 Q64150354-EED12052-6A50-4A38-B801-995E7D87CBE1 @default.
- Q64150354 P6099 Q64150354-8425BE08-2E4A-458D-8DEE-4508D9F5AEF6 @default.
- Q64150354 P8363 Q64150354-6EE803F9-5925-4C01-A51B-1E60B7BD18E7 @default.
- Q64150354 P1050 Q12206 @default.
- Q64150354 P1132 "+940" @default.
- Q64150354 P1476 "A Randomized, 24 Week, Active-controlled, Open-label, 3-arm, Parallel-group Multicenter Study Comparing the Efficacy and Safety of iGlarLixi to Insulin Glargine and Lixisenatide in Type 2 Diabetes Mellitus Patients Insufficiently Controlled With Oral Antidiabetic Drug(s)" @default.
- Q64150354 P17 Q865 @default.
- Q64150354 P1813 "Lixilan-O-AP" @default.
- Q64150354 P2899 "+18" @default.
- Q64150354 P3098 "NCT03798054" @default.
- Q64150354 P31 Q30612 @default.
- Q64150354 P4844 Q19484 @default.
- Q64150354 P4844 Q6659956 @default.
- Q64150354 P580 "2019-02-15T00:00:00Z" @default.
- Q64150354 P582 "2021-01-01T00:00:00Z" @default.
- Q64150354 P6099 Q42824827 @default.
- Q64150354 P8363 Q78089383 @default.